Dr. Charles S. Decarli, MD

Dr. Decarli practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Decarli's NPI, 1497728083, was assigned on February 13, 2006. Dr. Decarli graduated from George Washington University School of Medicine and Health Sciences in 1982. Dr. Decarli holds California license G85939.

Dr. Decarli's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Decarli's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Decarli to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Decarli practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Decarli's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Decarli is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Decarli's licenses on file in 4 states: California, New York, Maryland and District of Columbia.

Dmand AI lists alzheimer's disease, non-alzheimer's dementia (chronic) and vertigo among the conditions Dr. Decarli treats.

CMS data shows 26 Medicare services from Dr. Decarli across 2 procedure codes in 2024, for 26 Medicare patients. Medicare paid $1,105 for them. Every service was in an office.

CMS counts 26 Medicare patients who saw Dr. Decarli in 2024. The largest group is 65 to 74, with 11 patients. 75% of them have high cholesterol, and 62% have arthritis. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Decarli's median patient age at 69, with 54% women.

In 2023, Dr. Decarli wrote 32 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $1,269 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Decarli for performance year 2024, reported as part of a group. Dr. Decarli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 374 papers to Dr. Decarli, published from 2004 to 2025. 2024 was the busiest year, with 26. The most frequent topics are Magnetic Resonance Imaging, Brain and Alzheimer Disease. Dr. Decarli has published most often in Neurology. Dr. Decarli's most frequent co-authors are Sudha Seshadri, MD, Mitchell S. Elkind, MD and Hugo J. Aparicio, MD.

Dmand AI links Dr. Decarli to 1 clinical trial. Conditions studied include Alzheimer Disease and Tauopathies.

CMS Open Payments shows 81 general payments to Dr. Decarli from 5 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 67% of the total. Novartis Pharma AG paid the most, $76,330. It also lists 11 research payments totaling $56,381 from 2016 to 2022.

Dmand AI lists 2 awards for Dr. Decarli, most recently CMS Stage 1 EHR in 2012.

Dr. Decarli graduated from George Washington University School of Medicine and Health Sciences in 1982. Dr. Decarli is a member of AAN.

Dr. Decarli is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.